Song, Min Jong
Kim, Dae Hun
Kim, Su-Young
Kang, Noeul
Jhun, Byung Woo
Funding for this research was provided by:
National Research Foundation of Korea (2020R1C1C1008038)
Article History
Received: 21 January 2024
Accepted: 16 April 2024
First Online: 18 May 2024
Declarations
:
: This study was conducted on a subset of individuals from the NTM Registry of Samsung Medical Center (ClinicalTrials.gov: NCT0097080) and was approved by the Institutional Review Board (IRB) of Samsung Medical Center (IRB no. 2008-09-016). This study is an ongoing research project approved by the IRB to analyze clinical factors and human-derived materials, including sputum and NTM strains, for the investigation of the pathophysiology of NTM-PD patients. The IRB approval has been renewed annually (IRB no. 2008-09-016-041, latest update on November 3, 2023). All study subjects provided written informed consent.
: Not applicable.
: The authors declare no competing interests.